Endosonograpic Monitoring of Injury to the Anal Sphincter After Transanal Stapled Anastomosis
Study Details
Study Description
Brief Summary
Investigation of the sphincter muscles after low anterior or anterior rectum resection, and sigma resection operation by endoluminal ultrasound and manometrical examination.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Outcome Measures
Primary Outcome Measures
- EAUS [3 months postoperative]
Change in thickness of the anal sphincter muscles in mm from baseline to 3 months
Secondary Outcome Measures
- Endoanal manometry [3 months postoperative]
Change in Anal pressure in mmHg from baseline to 3 months
- EAUS2 [3 months postoperative]
Change in the defect grade of anal sphincter muscles from baseline to 3 months
- EAUS2-2 [12 months postoperative]
Change in thickness of the anal sphincter muscles in mm from baseline to 12 months
- EAUS2-2 [12 months postoperative]
Change in the defect grade of anal sphincter muscles from baseline to 12 months
- Endoanal manometry2 [12 months postoperative]
Change in Anal pressure in mmHg from baseline to 12 months
Other Outcome Measures
- LARS Score [3 months postoperative]
Change in LARS Score from baseline to 3 months
- LARS Score2 [12 months postoperative]
Change in LARS Score from baseline to 12 months
- LARS2 [12 months postoperative]
Change in LARS Score from baseline to 12 months
- Vaizey Score [3 months postoperative]
Change in Vaizey Score from baseline to 3 months
- Vaizey Score2 [12 months postoperative]
Change in Vaizey Score from baseline to 12 months
Eligibility Criteria
Criteria
Inclusion Criteria:
Age 18 - 90 years, undergoing transanal stapled anastomosis at the Department of General Surgery, Medical University of Vienna
-
Ability and willingness to understand and comply with study interventions and restrictions.
-
Voluntarily signed informed consent after full explanation of the study to the participant.
Exclusion Criteria:
-
Any physical or mental disorder, which could interfere with the participant's safety during the clinical trial or with the study objectives
-
Inability to communicate well with the investigator due to language problems or reduced mental development
-
Inability or unwillingness to give written informed consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Medical University of Vienna | Vienna | Austria | 1090 |
Sponsors and Collaborators
- Medical University of Vienna
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2192/2019